Regulacje i polityka gospodarcza · 27/10/1997

NIH to Grant Exclusive License for Synthetic, Anti-Complement Protein in Transplant Therapeutics

The National Institutes of Health (NIH) is considering granting an exclusive, worldwide license to Johns Hopkins University to use two patents related to synthetic, anti-complement proteins for transplant therapeutics, following a formal notice in accordance with US law.